Monsanto’s (MON) “Positive” Rating Reiterated at S&P Equity Research
S&P Equity Research reiterated their positive rating on shares of Monsanto Co. (NYSE:MON) in a research report sent to investors on Thursday morning, The Fly reports.
Other research analysts have also issued reports about the company. Sanford C. Bernstein restated a sell rating on shares of Monsanto in a research report on Sunday, May 29th. Piper Jaffray Cos. restated an overweight rating and issued a $127.00 price target (up from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Argus restated a buy rating and issued a $128.00 price target (up from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $122.43 price target on the stock in a research report on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. set a $92.00 price target on Monsanto and gave the stock a sell rating in a research report on Monday, June 27th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of $111.12.
Monsanto (NYSE:MON) opened at 101.80 on Thursday. The stock has a market cap of $44.55 billion, a P/E ratio of 44.81 and a beta of 1.24. The firm has a 50-day moving average price of $105.94 and a 200-day moving average price of $100.27. Monsanto has a 52 week low of $81.22 and a 52 week high of $114.26.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 29th. The company reported $2.17 EPS for the quarter, missing the Zacks’ consensus estimate of $2.40 by $0.23. The firm earned $4.19 billion during the quarter, compared to the consensus estimate of $4.49 billion. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The firm’s quarterly revenue was down 8.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.39 earnings per share. On average, equities research analysts predict that Monsanto will post $4.46 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is presently 89.26%.
In other news, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Several large investors have recently modified their holdings of the company. Macquarie Group Ltd. boosted its stake in shares of Monsanto by 49.2% in the second quarter. Macquarie Group Ltd. now owns 53,664 shares of the company’s stock worth $5,550,000 after buying an additional 17,692 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in shares of Monsanto during the second quarter worth about $1,824,000. Kentucky Retirement Systems purchased a new stake in shares of Monsanto during the second quarter worth about $3,841,000. Northwestern Mutual Investment Management Company LLC boosted its stake in shares of Monsanto by 2.6% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 372,340 shares of the company’s stock worth $38,504,000 after buying an additional 9,569 shares in the last quarter. Finally, Mason Street Advisors LLC purchased a new stake in shares of Monsanto during the second quarter worth about $6,085,000. Institutional investors own 79.22% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.